Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.
Prellis Biologics's investors include Plug and Play, Khosla Ventures, True Ventures, Civilization Ventures, Cantos.
Prellis Biologics is headquartered in Berkeley, United States.
Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.
Prellis Biologics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prellis Biologics — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/prellis-biologics. Accessed August 14, 2026.
VCBacked. (2025). Prellis Biologics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/prellis-biologics
{{cite web |title=Prellis Biologics — Funding & Investors |url=https://www.vcbacked.co/company/prellis-biologics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated